MD Mednax Inc

  1. Stocks
  2. Healthcare
  3. NYSE: MD

Price (delayed)

$24.43

Market cap

$2.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$9.55

Enterprise value

$2.77B

Sector: Healthcare
Industry: Medical Care Facilities

Highlights

The quick ratio has surged by 190% year-on-year and by 151% since the previous quarter
The net income rose by 47% year-on-year but it has declined by 10% since the previous quarter
The company's EPS rose by 47% YoY but it fell by 9% QoQ
The equity has shrunk by 50% YoY and by 7% QoQ
The revenue has decreased by 24% from the previous quarter and by 2.6% YoY

Key stats

What are the main financial stats of MD
Market
Shares outstanding
85.63M
Market cap
$2.09B
Enterprise value
$2.77B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.8
Price to sales (P/S)
1.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.6
Earnings
Revenue
$1.73B
EBIT
-$669.28M
EBITDA
-$640.84M
Free cash flow
$175.83M
Per share
EPS
-$9.55
Free cash flow per share
$2.11
Book value per share
$8.73
Revenue per share
$20.79
TBVPS
$22.1
Balance sheet
Total assets
$3.35B
Total liabilities
$2.6B
Debt
$1.8B
Equity
$747.49M
Working capital
$1.11B
Liquidity
Debt to equity
2.41
Current ratio
3.49
Quick ratio
3.31
Net debt/EBITDA
-1.06
Margins
EBITDA margin
-37%
Gross margin
25.9%
Net margin
-45.9%
Operating margin
5.7%
Efficiency
Return on assets
-22%
Return on equity
-82.4%
Return on invested capital
-26.2%
Return on capital employed
-23%
Return on sales
-38.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MD stock price

How has the Mednax stock price performed over time
Intraday
1.92%
1 week
11.05%
1 month
-6.4%
1 year
41.3%
YTD
-0.45%
QTD
-0.45%

Financial performance

How have Mednax's revenue and profit performed over time
Revenue
$1.73B
Gross profit
$449.32M
Operating income
$98.13M
Net income
-$796.49M
Gross margin
25.9%
Net margin
-45.9%
The net income rose by 47% year-on-year but it has declined by 10% since the previous quarter
The net margin has increased by 45% YoY but it has decreased by 44% from the previous quarter
MD's operating income is down by 43% year-on-year and by 10% since the previous quarter
The operating margin has declined by 41% year-on-year but it has increased by 19% since the previous quarter

Growth

What is Mednax's growth rate over time

Valuation

What is Mednax stock price valuation
P/E
N/A
P/B
2.8
P/S
1.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.6
The company's EPS rose by 47% YoY but it fell by 9% QoQ
The P/B is 65% above the 5-year quarterly average of 1.7 and 65% above the last 4 quarters average of 1.7
The equity has shrunk by 50% YoY and by 7% QoQ
The stock's price to sales (P/S) is 67% more than its last 4 quarters average of 0.7 but 22% less than its 5-year quarterly average of 1.5
The revenue has decreased by 24% from the previous quarter and by 2.6% YoY

Efficiency

How efficient is Mednax business performance
The company's return on sales rose by 50% YoY but it fell by 47% QoQ
The ROIC is up by 39% YoY but it is down by 31% from the previous quarter
MD's return on equity is down by 32% since the previous quarter and by 17% year-on-year
The ROA has grown by 27% YoY but it has contracted by 16% from the previous quarter

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Mednax financials performed over time
The total assets is 29% greater than the total liabilities
The quick ratio has surged by 190% year-on-year and by 151% since the previous quarter
The company's current ratio has surged by 159% YoY and by 3.3% QoQ
The debt is 141% more than the equity
MD's debt to equity has soared by 101% year-on-year and by 8% since the previous quarter
The equity has shrunk by 50% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.